What Was Normal Blood Pressure in 1950?

In the 1950s, there was no single universally agreed-upon threshold for “normal” blood pressure the way there is today. Many physicians at mid-century considered a systolic reading of 100 plus the patient’s age to be perfectly acceptable, meaning a 60-year-old with a systolic pressure of 160 mmHg would have been told everything was fine. What the medical world treated as normal then would today be classified as stage 2 hypertension, and the story of how that shift happened reveals just how recently we came to understand the damage that high blood pressure causes.

The “100 Plus Your Age” Rule

The most widely cited rule of thumb in mid-twentieth-century medicine held that normal systolic blood pressure was roughly 100 mmHg plus the patient’s age. Under this formula, a 50-year-old reading 150/90 was unremarkable. A 70-year-old at 170/95 was within expectations. The reasoning was straightforward and, in hindsight, dangerously wrong: as arteries stiffened with age, the heart supposedly needed to pump harder to push blood through narrower vessels. Elevated pressure, under this view, was the body’s natural and even beneficial adaptation to aging.

This was not a fringe belief. As late as the 1950s, many expert physicians openly argued that elevated blood pressure was necessary for adequate perfusion of vital organs, essentially that the body needed high pressure to keep the brain, kidneys, and heart supplied with blood.¹ Treating hypertension, from this perspective, risked starving the organs of the blood flow they depended on. The idea that lowering blood pressure could save lives was, for most clinicians of that era, genuinely counterintuitive.

Insurance Companies Knew What Doctors Didn’t

One of the more striking ironies of mid-century medicine is that life insurance actuaries had already figured out what most physicians still denied. Insurance companies had been collecting data on policyholders since the early 1900s, and by the 1930s and 1940s their tables clearly showed that people with higher blood pressure died sooner. Applicants with elevated readings were routinely denied coverage or charged higher premiums. The insurance industry treated high blood pressure as a quantifiable mortality risk decades before mainstream medicine accepted it as a disease worth treating.¹

This disconnect between the actuarial evidence and clinical practice persisted well into the 1950s. Physicians who saw patients every day and insurance statisticians who studied death rates at scale were looking at the same phenomenon and drawing opposite conclusions. The doctors saw a natural compensatory mechanism; the actuaries saw a risk factor. It took the emergence of large-scale epidemiological studies to close that gap.

The Framingham Turning Point

The study that did the most to change medical thinking about blood pressure launched in 1948 in Framingham, Massachusetts. Researchers enrolled thousands of residents and tracked their health over years and then decades, looking for patterns connecting risk factors to heart disease and stroke. The Framingham Heart Study established hypertension as a major cardiovascular risk factor, quantifying just how much damage elevated pressure inflicted on the heart and blood vessels over time.²

Framingham data from the 1950 cohort showed that sustained hypertension was already common. Among men in that cohort, roughly 138 out of every 1,000 had long-term sustained hypertension. Among women, the rate was even higher at about 253 per 1,000.³ These numbers represented people whose blood pressure stayed elevated over multiple years of follow-up, not one-off high readings in a doctor’s office. When you consider that many of these individuals were told by their doctors that their blood pressure was normal for their age, the scale of unrecognized disease becomes clear.

The Framingham findings didn’t change medical practice overnight. But they provided the kind of hard longitudinal evidence that slowly eroded the “100 plus your age” mindset and forced the profession to reckon with the fact that elevated blood pressure was not benign.

Why Diastolic Pressure Got All the Attention

Even as the medical community began to accept that hypertension was dangerous, it focused almost exclusively on the wrong number. For most of the twentieth century, clinicians fixated on diastolic blood pressure, the bottom number in a reading. Systolic pressure, the top number, was widely regarded as unreliable and less clinically meaningful. A patient with a reading of 170/85 might have been considered borderline because the diastolic number was close to acceptable, while the systolic reading that would alarm any modern physician was essentially ignored.

This diastolic fixation had real consequences. Multiple epidemiological studies and clinical trials eventually demonstrated that systolic blood pressure is actually a strong predictor of stroke, coronary heart disease, heart failure, and overall mortality, often a better predictor than diastolic pressure, especially in older adults.⁴ Overreliance on diastolic blood pressure was particularly misleading in elderly patients, many of whom had isolated systolic hypertension: a high top number with a normal or even low bottom number. Under mid-century logic, those patients looked fine. They were not fine.

The shift toward recognizing systolic pressure as equally or more important did not fully take hold until the 1990s and early 2000s. For decades, guidelines, textbooks, and clinical practice overwhelmingly prioritized diastolic readings, leaving a generation of patients with dangerous systolic hypertension untreated.

What Could Doctors Actually Do in the 1950s?

Part of the medical reluctance to diagnose or treat high blood pressure came from the fact that, frankly, there was not much physicians could do about it. Effective drug therapy for hypertension did not exist until the introduction of thiazide diuretics in 1958.⁵ Before that, the most severe cases of malignant hypertension, where blood pressure was dangerously and acutely elevated, carried a grim prognosis. Median survival was about 18 months for severe cases and as little as six months for the worst category.

The few available treatments were extreme. Around 1940, a physician named Walter Kempner developed the Rice Diet, an extremely low-sodium regimen providing less than 230 milligrams of sodium per day, a fraction of what most people eat. The diet consisted almost entirely of white rice, fruit, and sugar. It was miserable to follow but did demonstrate improved health and survival in some patients with severe hypertension.⁵ Surgical sympathectomy, which involved cutting nerves to reduce blood pressure, was another option for desperate cases, but it came with serious side effects including fainting, impotence, and bowel problems.

When the available treatments are that unpleasant and the side effects that severe, it becomes easier to understand why physicians preferred to tell patients their blood pressure was “normal for their age” rather than prescribe something that would make daily life miserable. The arrival of thiazide diuretics changed the calculus entirely. Suddenly there was a pill that could lower blood pressure without major side effects, and that changed the medical profession’s willingness to call high blood pressure a problem.

How the Numbers Have Shifted Since

The transformation from mid-century nonchalance to modern-day vigilance happened through a series of guideline revisions, each one ratcheting the definition of “high blood pressure” a little lower. Through the latter half of the twentieth century, the threshold for diagnosing hypertension settled at 140/90 mmHg, which was already a dramatic change from the “100 plus your age” standard. Then in 2017, the major U.S. cardiovascular guidelines lowered the threshold again to 130/80 mmHg, a change supported primarily by trial evidence showing that tighter blood pressure control reduced cardiovascular events.⁶

Under the 2017 guidelines, the category of “elevated blood pressure” now begins at a systolic reading of just 120 mmHg, and stage 1 hypertension starts at 130/80. To put that in perspective: a 50-year-old with a blood pressure of 150/90 would have been told they were perfectly healthy in 1950, would have been diagnosed with mild hypertension by the 1980s, and would be classified as having stage 2 hypertension today and likely prescribed medication. The biology hasn’t changed. The understanding of risk has.

Did People Actually Have Lower Blood Pressure Back Then?

This is worth separating from the question of what was considered “normal.” Regardless of where the diagnostic line was drawn, you might wonder whether people in the mid-twentieth century actually had different blood pressure readings than people today. The answer is complicated and somewhat surprising: population-wide blood pressure in the United States has actually trended downward over the past century.

An analysis of successive birth cohorts born between 1887 and 1975 found that both systolic and diastolic blood pressure decreased across the entire distribution. At the 50th percentile, systolic blood pressure dropped by roughly 2.4 mmHg per decade of birth year. The decline was even steeper at the high end: the 90th percentile of systolic pressure fell by about 4.6 mmHg per decade.⁷ The shift wasn’t limited to people already receiving treatment. It occurred across the whole population, from the lowest to the highest readings, suggesting that broad changes in diet, environment, and public health had a real effect.

Meanwhile, Framingham data tracked hypertension prevalence over time within a single community. Among men, the rate of sustained hypertension actually rose between the 1950 and 1970 cohorts, climbing from about 138 to 208 per 1,000. Among women, the opposite happened: rates fell from 253 to 198 per 1,000. Treatment rates, however, rose sharply in both sexes, increasing by roughly half between the 1950 and 1970 cohorts.³ So the picture is nuanced: the overall population distribution of blood pressure was shifting downward, but among specific groups, awareness and treatment were driving changes that the raw prevalence numbers alone don’t capture.

Is Rising Blood Pressure with Age Inevitable?

The “100 plus your age” formula rested on a deeper assumption: that blood pressure naturally and inevitably rises as you get older. In industrialized societies, this does appear to be broadly true. Average blood pressure climbs with each decade of life, and isolated systolic hypertension becomes extremely common past age 60. This is one reason mid-century doctors accepted higher readings in older patients as unremarkable.

But the pattern is not universal. In longitudinal studies of forager-horticulturalist populations living traditional lifestyles, blood pressure does not rise meaningfully with age. These are among the only populations on earth where the age-related climb in blood pressure essentially disappears.⁸ The implication is that rising blood pressure with age is not a biological inevitability baked into the aging process itself. It is a consequence of how we live: diets high in sodium and processed food, sedentary habits, chronic stress, and excess body weight. The 1950s doctors were right that blood pressure tends to go up with age. They were wrong about why, and wrong to conclude that the rise was therefore harmless.

From Threshold to Spectrum

One of the most fundamental conceptual shifts since the 1950s has nothing to do with specific numbers. It is the recognition that blood pressure-related risk does not suddenly switch on at some magic threshold. There is no reading below which blood pressure is harmless and above which it is dangerous. Instead, cardiovascular risk rises continuously across the entire range of blood pressure, starting well within what has always been considered “normal.”⁹

This understanding makes the question “what was normal?” even more revealing. In the 1950s, the medical profession treated blood pressure as essentially binary: you had hypertension or you didn’t, and the bar for having it was set very high. Today, the field has moved toward recognizing blood pressure as a continuous variable where every 10 mmHg reduction carries measurable benefits in terms of heart attack, stroke, and kidney disease risk. The old framework of “normal versus abnormal” has given way to a gradient of risk, which is why current guidelines break blood pressure into multiple categories: normal (below 120/80), elevated (120-129 systolic), stage 1 hypertension (130-139 systolic or 80-89 diastolic), and stage 2 hypertension (140 or higher systolic, or 90 or higher diastolic).⁶

A mid-century physician would find these fine-grained distinctions bewildering. Under their framework, even stage 2 hypertension in a 60-year-old might have been shrugged off. The shift isn’t just about where the line is drawn; it’s about whether a line is even the right way to think about it.

What the 1950s Got Wrong and What It Got Right

The errors of mid-century blood pressure thinking are well documented: the belief that high pressure was protective, the fixation on diastolic readings, the reluctance to treat. But the 1950s also saw the beginning of almost everything that would eventually correct those errors. The Framingham Heart Study launched in 1948. Kempner’s Rice Diet had already shown that lowering sodium could lower blood pressure. Thiazide diuretics arrived at the end of the decade, opening the door to practical treatment. The insurance actuarial data was sitting there, waiting for the clinical community to catch up.

The lag between evidence and practice is the real lesson. Life insurance companies had decades of mortality data showing that elevated blood pressure killed people. The medical profession took another generation to accept it, and another after that to develop effective treatments and guidelines. Even today, the debate over optimal targets continues: European guidelines have at times set different thresholds than American ones, and there is ongoing discussion about how aggressively to treat mild hypertension in low-risk patients. The numbers that define “normal” will likely continue to evolve as new trial data accumulates, just as they have been evolving since the days when 160/95 in a 60-year-old was nothing to worry about.

1
PubMed Central. Historical perspectives on the management of hypertension
2
Journal of Human Hypertension. Fifty years of Framingham Study contributions to understanding hypertension
3
PubMed. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990
4
American Heart Journal. Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile
5
PubMed Central. Modern perspective of the Rice Diet for hypertension and other metabolic diseases
6
PubMed Central. The Evolution of Blood Pressure Thresholds and Targets over Time: A Historical Review
7
PubMed. Birth cohort evidence of population influences on blood pressure in the United States, 1887-1994
8
PubMed Central. Does blood pressure inevitably rise with age?: longitudinal evidence among forager-horticulturalists
9
PubMed Central. Blood pressure and control of cardiovascular risk